Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Is there a comparable Mp-MRI for incidental prostate uptake on 18F-FDG PET/CT?

View through CrossRef
Abstract Purpose: Although 18F-FDG-PET/CT is helpful in defining many types of cancer, localized prostate cancer should not be treated with this technique. In this study, accidental 18F-FDG uptake in the prostate is described using multi-parametric MRI (mpMRI). Methods and Materials: While 18F-FDG-PET/CT is useful for characterizing a variety of cancers, it is not advised for prostate cancer that is localized. This work investigates the use of mpMRI to describe incidental 18F-FDG uptake in the prostate.mpMRI included T2-weighted (T2W), dynamic contrast enhancement (DCE), and apparent diffusion coefficient (ADC) sequences. Patients were classified according to PI-RADS (Prostate Imaging Reporting and Data System) version 2.1 by an experienced uroradiologist, and 18F-FDG-PET was evaluated to determine whether the area of involvement on CT had a counterpart in mpMRI. A biopsy was performed on 30 of the 92 patients.These patients' maximum standardized uptake values (SUVmax) 6 < and ≥ 6, PS(PSA) density 0.15< and ≥ 0.15, PSA level, uptake pattern (focal involvement/diffuse involvement), and PI-RADS scores were compared. P < 0.05 was considered statistically significant. Results: In the study, 92 patients with incidental 18F-FDG-PET/CT prostate uptake were examined. Median age was 66, PSA median was 3.6 ng/ml (range: 0-3198 ng/ml). Notably, in 70.6% of cases, PET/CT uptake didn't correlate with mp-MRI findings. Among PI-RADS 3-4-5 patients (29.3%), there was a correlation. Biopsies in 30 patients revealed 43.3% benign, 56.7% malignant. Significant differences between benign and malignant cases were observed in PSA density, PI-RADS scores, and PSA levels (p < 0.05), while SUVmax and uptake pattern were not significant. Conclusions: Our study showed that incidental 18F-FDG-PET/CT prostate uptake was detected and that high PSA density values, PI-RADS scores, and PSA values, such as in routine patients, and not PET-CT findings such as SUVmax and uptake pattern, were more predictive of malignancy.
Title: Is there a comparable Mp-MRI for incidental prostate uptake on 18F-FDG PET/CT?
Description:
Abstract Purpose: Although 18F-FDG-PET/CT is helpful in defining many types of cancer, localized prostate cancer should not be treated with this technique.
In this study, accidental 18F-FDG uptake in the prostate is described using multi-parametric MRI (mpMRI).
Methods and Materials: While 18F-FDG-PET/CT is useful for characterizing a variety of cancers, it is not advised for prostate cancer that is localized.
This work investigates the use of mpMRI to describe incidental 18F-FDG uptake in the prostate.
mpMRI included T2-weighted (T2W), dynamic contrast enhancement (DCE), and apparent diffusion coefficient (ADC) sequences.
Patients were classified according to PI-RADS (Prostate Imaging Reporting and Data System) version 2.
1 by an experienced uroradiologist, and 18F-FDG-PET was evaluated to determine whether the area of involvement on CT had a counterpart in mpMRI.
A biopsy was performed on 30 of the 92 patients.
These patients' maximum standardized uptake values (SUVmax) 6 < and ≥ 6, PS(PSA) density 0.
15< and ≥ 0.
15, PSA level, uptake pattern (focal involvement/diffuse involvement), and PI-RADS scores were compared.
P < 0.
05 was considered statistically significant.
Results: In the study, 92 patients with incidental 18F-FDG-PET/CT prostate uptake were examined.
Median age was 66, PSA median was 3.
6 ng/ml (range: 0-3198 ng/ml).
Notably, in 70.
6% of cases, PET/CT uptake didn't correlate with mp-MRI findings.
Among PI-RADS 3-4-5 patients (29.
3%), there was a correlation.
Biopsies in 30 patients revealed 43.
3% benign, 56.
7% malignant.
Significant differences between benign and malignant cases were observed in PSA density, PI-RADS scores, and PSA levels (p < 0.
05), while SUVmax and uptake pattern were not significant.
Conclusions: Our study showed that incidental 18F-FDG-PET/CT prostate uptake was detected and that high PSA density values, PI-RADS scores, and PSA values, such as in routine patients, and not PET-CT findings such as SUVmax and uptake pattern, were more predictive of malignancy.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Diagnostic value of 18F-FDG PET/MRI for staging in patients with ovarian cancer
Diagnostic value of 18F-FDG PET/MRI for staging in patients with ovarian cancer
Abstract Purpose: To evaluate the diagnostic potential of PET/MRI with 18F-fluorodeoxyglucose (18F-FDG) in ovarian cancer.Materials and Methods: Participants comprised 103 ...
Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer
Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer
Abstract Purpose: To evaluate the diagnostic potential of PET/MRI with 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) in ovarian cancer.Materials and Methods: Participants comp...
Diagnostic Value of 18F-FDG PET/MRI For Staging in Patients With Ovarian Cancer
Diagnostic Value of 18F-FDG PET/MRI For Staging in Patients With Ovarian Cancer
Abstract Purpose To evaluate the diagnostic potential of PET/MRI with 18F-fluorodeoxyglucose (18F-FDG) in ovarian cancer. Materials and Methods Participants comprised 103...
Bridging bones
Bridging bones
Chapter 2 presents the evaluation of the feasibility of utilizing whole-body [18F]Fluoride PET/CT for visualizing molecular new bone formation in clinically active PsA patients. Th...
Baseline Staging Evaluation in Lymphoma: The Role of FDG PET, CT, and Bone Marrow Biopsy
Baseline Staging Evaluation in Lymphoma: The Role of FDG PET, CT, and Bone Marrow Biopsy
Abstract Abstract 2640 BACKGROUND: The revised response criteria for malignant lymphoma (Cheson et al JCO 25:579 ...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...

Back to Top